To determine the timing of onset of contraceptive effectiveness after the first injection of 150 mg of depot medroxyprogesterone acetate (DMPA) administered between days 8 and 13 of the menstrual cycle. Descriptive, prospective study. A tertiary university referral center. Thirty healthy women between 18 and 40 years of age. Volunteers were injected with DMPA between days 8 and 13 (5 women on each day) of the menstrual cycle. Ovarian function determined by serum levels of E2 and progesterone and follicular development evaluated by vaginal ultrasound. In nine (30%) of 30 women studied, DMPA did not prevent ovulation. All ovulations occurred in women receiving DMPA between days 10 and 13 of the cycle. No woman who received injections on day 8...
UnrestrictedBackground: Subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) has not been studied...
Subject: This was a prospective study of efficacy and safety of injection depot medroxy progesterone...
Objective: To test the feasibility of timing the administration of mifepristone as a once-a-month co...
Objective: To assess whether women who were administered the first injection of DMPAcE+E(2)C on day ...
Objective: To evaluate the changes in cervical mucus within the first hours or days after depot medr...
The objectives of this study were to assess whether women who were administered the first injection ...
Introduction; the use of injectable contraceptives can effectively prevent pregnancy up to 99%-100%,...
The high rate of unintended pregnancies and the relative failure rates with the typical use of rever...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)The aim of this study was to com...
2019-05-06Background: The use of emergency contraception (EC) in the United States has increased ove...
Latar belakang: Kontrasepsi hormonal injeksi masih banyak digunakan di berbagai negara berkembang, t...
The use of Depo Medroksiprogesteron Asetat ( DMPA ) can give side effects to the change of menstrual...
Summary. In rats injected with depo-medroxyprogesterone acetate(depo-MPA) at either 10.00 or 22.00 h...
Medroxyprogesterone acetate (Depo-Provera) is now approved for use as an injectable contraceptive. I...
Background: Depot medroxyprogesterone (DMPA) injection 150 mg intramuscular was used in postpartum w...
UnrestrictedBackground: Subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) has not been studied...
Subject: This was a prospective study of efficacy and safety of injection depot medroxy progesterone...
Objective: To test the feasibility of timing the administration of mifepristone as a once-a-month co...
Objective: To assess whether women who were administered the first injection of DMPAcE+E(2)C on day ...
Objective: To evaluate the changes in cervical mucus within the first hours or days after depot medr...
The objectives of this study were to assess whether women who were administered the first injection ...
Introduction; the use of injectable contraceptives can effectively prevent pregnancy up to 99%-100%,...
The high rate of unintended pregnancies and the relative failure rates with the typical use of rever...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)The aim of this study was to com...
2019-05-06Background: The use of emergency contraception (EC) in the United States has increased ove...
Latar belakang: Kontrasepsi hormonal injeksi masih banyak digunakan di berbagai negara berkembang, t...
The use of Depo Medroksiprogesteron Asetat ( DMPA ) can give side effects to the change of menstrual...
Summary. In rats injected with depo-medroxyprogesterone acetate(depo-MPA) at either 10.00 or 22.00 h...
Medroxyprogesterone acetate (Depo-Provera) is now approved for use as an injectable contraceptive. I...
Background: Depot medroxyprogesterone (DMPA) injection 150 mg intramuscular was used in postpartum w...
UnrestrictedBackground: Subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) has not been studied...
Subject: This was a prospective study of efficacy and safety of injection depot medroxy progesterone...
Objective: To test the feasibility of timing the administration of mifepristone as a once-a-month co...